Intrinsic Value of S&P & Nasdaq Contact Us

Alector, Inc. ALEC NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.25
+34.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Alector, Inc. (ALEC) has a negative trailing P/E of -1.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -58.43%.

Criteria proven by this page:

  • VALUE (97/100, Pass) — analyst target implies upside (+34.9%).
  • Trailing Earnings Yield -58.43% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $3.25 (+34.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 42/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
42/100
SG Score
View full scorecard →
VALUE
97/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ALEC

Valuation Multiples
P/E (TTM)-1.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio7.98
P/S Ratio12.45
EV/EBITDA-1.7
Per Share Data
EPS (TTM)$-1.39
Book Value / Share$0.30
Revenue / Share$0.20
FCF / Share$-1.79
Yields & Fair Value
Earnings Yield-58.43%
Dividend Yield0.00%
Analyst Target$3.25 (+34.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -10.1 0.00 -6.14 367.68 -
2017 -28.4 0.44 -17.72 246.86 -
2018 -23.6 -1.14 -12.63 44.46 -
2019 -10.1 -0.09 5.46 50.13 -
2020 -6.2 -0.12 4.40 55.76 -
2021 -45.7 0.56 5.52 8.02 -
2022 -5.7 -0.02 3.55 5.70 -
2023 -5.1 1.38 4.98 6.88 -
2024 -1.5 0.07 1.44 1.82 -
2025 -1.1 -0.09 5.24 7.63 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.29 $416K $-15.11M -3632.2%
2017 $-0.63 $3.74M $-32.48M -869.6%
2018 $-0.76 $27.68M $-52.25M -188.8%
2019 $-1.62 $21.22M $-99.81M -470.4%
2020 $-2.35 $21.1M $-182.96M -867.2%
2021 $-0.35 $207.09M $-28.01M -13.5%
2022 $-1.62 $133.62M $-133.31M -99.8%
2023 $-1.56 $97.06M $-130.39M -134.3%
2024 $-1.23 $100.56M $-119.05M -118.4%
2025 $-1.39 $21.05M $-142.93M -679.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.92 $-1.62 – $0.49 $36.71M $6.32M – $90.64M 7
2027 $-0.88 $-1.34 – $-0.44 $15.5M $10.06M – $20.93M 6
2028 $-0.83 $-1.11 – $-0.45 $14.9M $4.06M – $33.3M 4
2029 $-0.66 $-1.71 – $-0.04 $20.76M $5.65M – $46.38M 2
2030 $-0.38 $-0.99 – $-0.02 $52.34M $14.25M – $116.96M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message